Lord, Abbett & Co. LLC Natera, Inc. Transaction History

Lord, Abbett & Co. LLC

$31.4 Billion
Q3 2024

A detailed history of Lord, Abbett & Co. LLC transactions in Natera, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 1,509,231 shares of NTRA stock, worth $241 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

1,509,231

Previous 1,509,231 -0.0%

Holding current value

$241 Million

Previous $192 Million -0.0%

% of portfolio

0.61%

Previous 0.62%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$97.75 - $129.67 $45.4 Million - $60.2 Million	-464,491 Reduced 23.53%	1,509,231 $192 Million
Q2 2024 Oct 07, 2024	BUY	$85.28 - $112.6 $15.1 Million - $20 Million	177,412 Added 9.88%	1,973,722 $214 Million
Q2 2024 Aug 14, 2024	BUY	$85.28 - $112.6 $15.1 Million - $20 Million	177,412 Added 9.88%	1,973,722 $214 Million
Q1 2024 Oct 07, 2024	BUY	$59.21 - $92.9 $59 Million - $92.6 Million	996,821 Added 124.68%	1,796,310 $164 Million
Q1 2024 May 09, 2024	BUY	$59.21 - $92.9 $59 Million - $92.6 Million	996,821 Added 124.68%	1,796,310 $164 Million
Q4 2023 Oct 07, 2024	BUY	$37.55 - $62.64 $6.81 Million - $11.4 Million	181,362 Added 29.34%	799,489 $50.1 Million
Q4 2023 Feb 12, 2024	BUY	$37.55 - $62.64 $6.81 Million - $11.4 Million	181,362 Added 29.34%	799,489 $50.1 Million
Q3 2023 Oct 07, 2024	SELL	$43.4 - $62.52 $5.89 Million - $8.49 Million	-135,759 Reduced 18.01%	618,127 $27.4 Million
Q3 2023 Nov 13, 2023	SELL	$43.4 - $62.52 $5.89 Million - $8.49 Million	-135,759 Reduced 18.01%	618,127 $27.4 Million
Q2 2023 Oct 07, 2024	SELL	$47.08 - $55.16 $5.57 Million - $6.53 Million	-118,359 Reduced 13.57%	753,886 $36.7 Million
Q2 2023 Aug 14, 2023	SELL	$47.08 - $55.16 $5.57 Million - $6.53 Million	-118,359 Reduced 13.57%	753,886 $36.7 Million
Q1 2023 Oct 07, 2024	BUY	$36.57 - $58.29 $10.9 Million - $17.4 Million	298,420 Added 52.01%	872,245 $48.4 Million
Q1 2023 May 12, 2023	BUY	$36.57 - $58.29 $10.9 Million - $17.4 Million	298,420 Added 52.01%	872,245 $48.4 Million
Q4 2022 Oct 07, 2024	SELL	$34.17 - $47.91 $47.8 Million - $67.1 Million	-1,399,897 Reduced 70.93%	573,825 $23.1 Million
Q4 2022 Feb 10, 2023	BUY	$34.17 - $47.91 $8.05 Million - $11.3 Million	235,561 Added 69.64%	573,825 $23.1 Million
Q3 2022 Nov 14, 2022	BUY	$36.93 - $56.68 $12.5 Million - $19.2 Million	338,264 New	338,264 $14.8 Million
Q2 2022 Aug 12, 2022	SELL	$28.13 - $44.54 $3.15 Million - $4.99 Million	-112,138 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$30.32 - $91.33 $14.1 Million - $42.6 Million	-466,587 Reduced 80.62%	112,138 $4.56 Million
Q4 2021 Feb 11, 2022	SELL	$86.26 - $119.0 $32.8 Million - $45.3 Million	-380,552 Reduced 39.67%	578,725 $54 Million
Q3 2021 Nov 09, 2021	SELL	$100.17 - $126.36 $3.88 Million - $4.9 Million	-38,779 Reduced 3.89%	959,277 $107 Million
Q2 2021 Aug 11, 2021	SELL	$86.05 - $119.72 $40.5 Million - $56.3 Million	-470,141 Reduced 32.02%	998,056 $113 Million
Q1 2021 May 11, 2021	BUY	$91.47 - $124.36 $44.6 Million - $60.6 Million	487,579 Added 49.72%	1,468,197 $149 Million
Q4 2020 Feb 09, 2021	SELL	$66.66 - $111.74 $401,693 - $673,345	-6,026 Reduced 0.61%	980,618 $97.6 Million
Q3 2020 Nov 12, 2020	BUY	$45.89 - $72.67 $7.33 Million - $11.6 Million	159,804 Added 19.33%	986,644 $71.3 Million
Q2 2020 Aug 14, 2020	BUY	$26.36 - $49.86 $7.46 Million - $14.1 Million	282,976 Added 52.03%	826,840 $41.2 Million
Q1 2020 May 14, 2020	BUY	$17.27 - $40.17 $705,479 - $1.64 Million	40,850 Added 8.12%	543,864 $16.2 Million
Q4 2019 Feb 14, 2020	BUY	$32.1 - $40.4 $11.3 Million - $14.2 Million	350,488 Added 229.79%	503,014 $16.9 Million
Q3 2019 Nov 14, 2019	BUY	$25.38 - $34.89 $3.87 Million - $5.32 Million	152,526 New	152,526 $5 Million

Others Institutions Holding NTRA

# of Institutions

527

Shares Held

118M

Call Options Held

308K

Put Options Held

191K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $15.5B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account

Lord, Abbett & Co. LLC Natera, Inc. Transaction History